Diversified Green Biocides Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1052.03%
- Profit Growth -72.97%
- Ebitda 69.17%
- Net Worth -195.50%
- Total Assets 207.52%
About Diversified Green Biocides
Diversified Green Biocides Private Limited (DGBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 19 January 2017 (Eight years 26 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rina Mediratta and Dhananjai Mediratta serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24290DL2017PTC310800
-
Company No.
310800
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jan 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Diversified Green Biocides?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rina Mediratta
|
Director | 19-Jan-2017 | Current |
|
Dhananjai Mediratta
|
Director | 19-Jan-2017 | Current |
Financial Performance of Diversified Green Biocides.
Diversified Green Biocides Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1052.03% increase. The company also saw a substantial fall in profitability, with a 72.97% decrease in profit. The company's net worth observed a substantial decline by a decrease of 195.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diversified Green Biocides?
In 2018, Diversified Green Biocides had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Spring Fresh Water Treatments LimitedRina Mediratta and Dhananjai Mediratta are mutual person
-
Modcarb India Private LimitedRina Mediratta and Dhananjai Mediratta are mutual person
-
Inteco Colloids Private Limited
Rina Mediratta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diversified Green Biocides?
Unlock and access historical data on people associated with Diversified Green Biocides, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diversified Green Biocides, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diversified Green Biocides's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.